期刊文献+

长效人促卵泡激素CHO细胞株的构建及其体内活性

Expression of human long-acting FSH in CHO cell and its bioactivity in vivo
原文传递
导出
摘要 促卵泡激素(FSH)是具有促进卵泡与睾丸发育作用的一种垂体糖蛋白激素。因其体内半衰期较短,临床上需要连续10 d以上每天注射,病人使用非常不方便。本文旨在通过提高糖基化程度,研制一种长效FSH。通过一段含有两个N-糖基化位点的连接序列,将人FSHα链与β链cDNA融合,并插入pcDNA3.1(+)表达载体。表达载体转染CHO-K1细胞后,通过G418筛选得到阳性单克隆细胞,并经PCR和Western blotting证实。该重组FSH为单链蛋白,分子量约为49 kDa。经无血清培养,工程细胞株培养上清液中重组FSH的表达量可达3 mg/L。单次注射该重组FSH能够促进大鼠卵巢发育与卵泡成熟,且药效与连续8次注射Folltropin-V的相近。实验结果显示,本研究已成功获得一种长效重组FSH。 Follicle-stimulating hormone (FSH) is a pituitary glycoprotein hormone that is essential for the development of ovarian follicles and testicular seminiferous tubules. The relatively short half-life of FSH in vivo requires daily injections for more than 10 days that is inconvenient and possibly contribute to the stress perceived by the patients. The goal of the present study was to increase FSH glycosylation, in order to develop a long-acting recombinant FSH. The cDNA of native α and β subunit of human FSH was linked by a sequence with two N-linked glycosylation sites, and the resulted DNA was inserted into pcDNA3.1 vector to generate a recombinant vector of pcDNA3.1-FSH. The pcDNA3.1-FSH was linearized and transfected into CHO-K1, positive transformants were selected by G418 and confirmed by PCR and Western blotting. A single chain recombinant FSH was expressed, with molecular weight of about 49 kDa. The recombinant FSH expression level in CHO-K1 cell strain in serum-free culture was 3 mg/L. Single injection of this recombinant FSH could induce folliculogenesis and ovulation in rats, the efficacy was similar with the commercially available FSH preparation (Folltropin-V) administrated 8 times consecutively. The results suggested a long-acting FSH was produced successfully.
出处 《生物工程学报》 CAS CSCD 北大核心 2014年第6期954-961,共8页 Chinese Journal of Biotechnology
基金 国家自然科学基金(No.81271691) 国际科技合作项目(No.2011DFG33320) 福建省科技重大项目(No.2013N5007) 华侨大学校级基金(No.11HZR19)资助~~
关键词 促卵泡激素 CHO—K1细胞 长效 无血清培养 follicle-stimulating hormone, Chinese hamster ovary cells, long acting, serum-free culture
  • 相关文献

参考文献27

  • 1Kim DJ,Seok SH,Baek MW,et al.Highly expressed recombinant human follicle-stimulatinghormone from Chinese hamster ovary cells grownin serum-free medium and its effect on induction offolliculogenesis and ovulation.Fertil Steril,2010,93(8):2652–2660.
  • 2Ulloa-Aguirre A,Timossi C.Structure-functionrelationship of follicle-stimulating hormone and itsreceptor.Hum Reprod Update,1998,4(3):260–283.
  • 3Kumar TR,Wang Y,Lu N,et al.Folliclestimulating hormone is required for ovarian folliclematuration but not male fertility.Nat Genet,1997,15(2):201–204.
  • 4Fan QR,Hendrickson WA.Structure of humanfollicle-stimulating hormone in complex with itsreceptor.Nature,2005,433:269–277.
  • 5Fan QR,Hendrickson WA.Comparative structuralanalysis of the binding domain of folliclestimulating hormone receptor.Proteins,2008,72(1):393–401.
  • 6Ruman JI,Pollak S,Trousdale RK,et al.Effects oflong-acting recombinant human follicle-stimulatinghormone analogs containing N-linked glycosylationon murine folliculogenesis.Fertil Steril,2005,83(4):1303–1309.
  • 7Weenen C,Pena J,Pollak S,et al.Long-actingfollicle-stimulating hormone analogs containingN-linked glycosylation exhibited increased bioactivitycompared with O-linked analogs in female rats.J ClinEndocr Metab,2004,89(10):5204–5212.
  • 8Hugues JN.Recombinant human follicle-stimulatinghormone:a scientific step to clinical improvement.Reprod Biomed Online,2001,2(1):54–64.
  • 9杨欢利,赵西彪,宋晓娟,丁家桐.山羊重组促卵泡素长效类似物基因在毕赤酵母中表达[J].生物工程学报,2008,24(3):409-414. 被引量:1
  • 10Kumar TR,Schuff KG,Nusser KD,et al.Gonadotroph-specific expression of the humanfollicle stimulating hormone beta gene intransgenic mice.Mol Cell Endocrinol,2006,247(1/2):103–115.

二级参考文献50

  • 1孙雪萍,严正杰,杨欢利,刘燕杰,丁家桐.山羊FSH类似物基因构建及其表达[J].畜牧兽医学报,2006,37(12):1250-1253. 被引量:2
  • 2Gibreel A, Bhattacharya S. Recombinant follitropin all'a/ lutropin alfa in fertility treatment [J]. Biologics, 2010, 4: 5-17.
  • 3Seyhan A, Ata B. The role ofcorifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist [J]. lnt J Womens Health, 2011,3: 243-255.
  • 4Fauser BC, Mannaerts BM, Devroey E et al. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency [J]. Hum Reprod Update, 2009,.
  • 5Solfi R J, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy [J]. BioDrugs, 2010, 24: 9-21.
  • 6Fares FA. The role of O-linked and N-linked oligosaccharideson the structure-function of glyeoprotein hormones: development ofagonists and antagonists [J]. Bioehim Biophys Acta, 2006, 1760: 560-567.
  • 7solā RJ, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals [J]. J Pharm Sci, 2009, 98: 1223-1245.
  • 8Li H, d'Anjou M. Pharmacological significance of glycosylafion in therapeutic proteins [J]. Curr Opin Biotechnol, 2009, 20: 678-684.
  • 9Ben-Menahem D, Grotjan HE. Strategies for construction of luteinizing hormone beta subunit analogs with carboxyl terminal extensions in non-primate, non-equid mammalian species [J]. Mol Cell Endocrinol, 2007, 260-262: 205-211.
  • 10Fares FA, Suganuma N, Nishimori K, et al. Design of a long- acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit [J]. Proc Natl Acad Sci USA, 1992, 89: 4304-4308.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部